4.2.1Consolidated Income Statement
in millions of US$ |
Notes |
2018 |
20171 |
---|---|---|---|
Revenue from contracts with customers |
1,744 |
1,248 |
|
Interest revenue from finance lease calculated using the effective interest method |
496 |
613 |
|
Total revenue |
2,240 |
1,861 |
|
Cost of sales |
(1,437) |
(1,063) |
|
Gross margin |
802 |
798 |
|
Other operating income/(expense) |
(30) |
(239) |
|
Selling and marketing expenses |
(36) |
(36) |
|
General and administrative expenses |
(122) |
(132) |
|
Research and development expenses |
(23) |
(33) |
|
Net impairment gains/(losses) on financial and contract assets |
13 |
(1) |
|
Operating profit/(loss) (EBIT) |
603 |
358 |
|
Financial income |
46 |
27 |
|
Financial expenses |
(279) |
(358) |
|
Net financing costs |
(233) |
(331) |
|
Share of profit/(loss) of equity-accounted investees |
13 |
(2) |
|
Profit/(loss) before tax |
384 |
25 |
|
Income tax expense |
(40) |
(26) |
|
Profit/(loss) |
344 |
(1) |
|
Attributable to shareholders of the parent company |
212 |
(155) |
|
Attributable to non-controlling interests |
132 |
154 |
|
Profit/(loss) |
344 |
(1) |
- 1 Restated to separately present net impairment losses on financial and contract assets following IFRS 9 implementation
Earnings/(loss) per share
Notes |
2018 |
2017 |
|
---|---|---|---|
Weighted average number of shares outstanding |
204,270,610 |
202,849,287 |
|
Basic earnings/(loss) per share |
US$ 1.04 |
US$ (0.76) |
|
Fully diluted earnings/(loss) per share |
US$ 1.04 |
US$ (0.76) |